UB Paderborn / Katalog / Suche / in CDI

Metabolism of [14C]gemopatrilat after oral administration to rats, dogs, and humans

Drug metabolism and disposition, 2006-06, Vol.34 (6), p.961

2006

Volltextzugriff (PDF)

Protein covalent binding of maxipost through a cytochrome P450-mediated ortho-quinone methide intermediate in rats

Drug metabolism and disposition, 2003-07, Vol.31 (7), p.837

2003

Volltextzugriff (PDF)

Carbon-14-and carbon-13-labeled phosphoric acid [2-4-(4-cyanophenyl)-thiazol-2-yl]-(2,4-difluorophenyl)-1-[1,2,4]triazol-4-yl-methylpropoxymethyl] monoester dilysine salt, a prodrug of ravuconazole

Journal of labelled compounds & radiopharmaceuticals, 2011-06, Vol.54 (7), p.357-362

2011

Volltextzugriff (PDF)

Synthesis of a labeled inhibitor of HIV-1 attachment: 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridinyl-3-yl-[U-14C]ethane-1,2-dione, BMS-488043-14C

Journal of labelled compounds & radiopharmaceuticals, 2011-05, Vol.54 (6), p.289-291

2011

Volltextzugriff (PDF)

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

Antimicrobial Agents and Chemotherapy, 1999-01, Vol.43 (1), p.190-193

1999

Volltextzugriff (PDF)

Outcomes of Orthopaedic Infections in Recreational Intravenous Drug Users Requiring Long-term Antibiotic Treatment

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2022-06, Vol.6 (6)

2022

Volltextzugriff (PDF)

Comparative biotransformation of radiolabeled [(14)C]omapatrilat and stable-labeled [(13)C(2)]omapatrilat after oral administration to rats, dogs, and humans

Drug metabolism and disposition, 2003-01, Vol.31 (1), p.67

2003

Volltextzugriff (PDF)

The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Journal of labelled compounds & radiopharmaceuticals, 2011-05, Vol.54 (6), p.324-331

2011

Volltextzugriff (PDF)

Synthesis of multi-labeled [14C]Aripiprazole

Journal of labelled compounds & radiopharmaceuticals, 2006-01, Vol.49 (1), p.1-9

2006

Volltextzugriff (PDF)

Synthesis of the anxiolytic agent [14C] 6-hydroxy-buspirone for use in a human ADME study

Journal of labelled compounds & radiopharmaceuticals, 2007-02, Vol.50 (2), p.65-71

2007

Volltextzugriff (PDF)

Synthesis of [14C]-radiolabelled entecavir

Journal of labelled compounds & radiopharmaceuticals, 2005-08, Vol.48 (9), p.645-655

2005

Volltextzugriff (PDF)

Metabolism of [(14)C]omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humans

Drug metabolism and disposition, 2001-01, Vol.29 (1), p.60

2001

Volltextzugriff (PDF)

Synthesis of 14C-labeled and 13C-,15N-labeled dasatinib and its piperazine N-dealkyl metabolite

Journal of labelled compounds & radiopharmaceuticals, 2008-01, Vol.51 (1), p.41-47

2008

Volltextzugriff (PDF)

Shoulder Surgery: Tricks of the Trade

1, 2019

Volltextzugriff (PDF)

A facile and efficient synthesis of d3-labelled Reyataz

Journal of labelled compounds & radiopharmaceuticals, 2005-12, Vol.48 (14), p.1041-1047

2005

Volltextzugriff (PDF)

Carbon‐14‐and carbon‐13‐labeled phosphoric acid [2‐4‐(4‐cyanophenyl)‐thiazol‐2‐yl]‐(2,4‐difluorophenyl)‐1‐[1,2,4]triazol‐4‐yl‐methylpropoxymethyl] mono ester dilysine salt, a prodrug of ravuconazole

Journal of labelled compounds & radiopharmaceuticals, 2011-06, Vol.54 (7), p.357-362

2011

Volltextzugriff (PDF)

Synthesis of a labeled inhibitor of HIV‐1 attachment: 1‐(4‐benzoylpiperazin‐1‐yl)‐2‐(4,7‐dimethoxy‐1H‐pyrrolo[2,3‐c]pyridinyl‐3‐yl‐[U‐ 14 C]ethane‐1,2‐dione, BMS‐488043‐ 14 C

Journal of labelled compounds & radiopharmaceuticals, 2011-05, Vol.54 (6), p.289-291

2011

Volltextzugriff (PDF)

Shoulder Surgery: Tricks of the Trade

Volltextzugriff (PDF)

Synthesis of [13C4]Baraclude® (entecavir)

Journal of labelled compounds & radiopharmaceuticals, 2009-09, Vol.52 (11), p.485-489

2009

Volltextzugriff (PDF)

Synthesis and stability of a carbon-14-labeled 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor

Journal of labelled compounds & radiopharmaceuticals, 2011-02, Vol.54 (2), p.72-79

2011

Volltextzugriff (PDF)

Synthesis of lead LFA-1 antagonist [14C]spyrocyclic hydantoin

Journal of labelled compounds & radiopharmaceuticals, 2009-05, Vol.52 (6), p.236-242

2009

Volltextzugriff (PDF)

The 14 C, 13 C, and 15 N syntheses of a potent VEGFR‐2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Journal of labelled compounds & radiopharmaceuticals, 2011-05, Vol.54 (6), p.324-331

2011

Volltextzugriff (PDF)

Synthesis of [13C4,15N2lpyrrolo[2,1-f][1,2,4]triazinone

Journal of labelled compounds & radiopharmaceuticals, 2006, Vol.49 (2), p.139-145

2006

Volltextzugriff (PDF)

Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats

Drug metabolism and disposition, 1998-10, Vol.26 (10), p.993

1998

Volltextzugriff (PDF)

Synthesis of 14 C‐labeled and 13 C‐, 15 N‐labeled dasatinib and its piperazine N ‐dealkyl metabolite

Journal of labelled compounds & radiopharmaceuticals, 2008-01, Vol.51 (1), p.41-47

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Metabolism of [14C]gemopatrilat after oral administration to rats, dogs, and humans

Protein covalent binding of maxipost through a cytochrome P450-mediated ortho-quinone methide intermediate in rats

Carbon-14-and carbon-13-labeled phosphoric acid [2-4-(4-cyanophenyl)-thiazol-2-yl]-(2,4-difluorophenyl)-1-[1,2,4]triazol-4-yl-methylpropoxymethyl] monoester dilysine salt, a prodrug of ravuconazole

Synthesis of a labeled inhibitor of HIV-1 attachment: 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridinyl-3-yl-[U-14C]ethane-1,2-dione, BMS-488043-14C

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

Outcomes of Orthopaedic Infections in Recreational Intravenous Drug Users Requiring Long-term Antibiotic Treatment

Comparative biotransformation of radiolabeled [(14)C]omapatrilat and stable-labeled [(13)C(2)]omapatrilat after oral administration to rats, dogs, and humans

The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Synthesis of multi-labeled [14C]Aripiprazole

Synthesis of the anxiolytic agent [14C] 6-hydroxy-buspirone for use in a human ADME study

Synthesis of [14C]-radiolabelled entecavir

Metabolism of [(14)C]omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humans

Synthesis of 14C-labeled and 13C-,15N-labeled dasatinib and its piperazine N-dealkyl metabolite

Shoulder Surgery: Tricks of the Trade

A facile and efficient synthesis of d3-labelled Reyataz

Carbon‐14‐and carbon‐13‐labeled phosphoric acid [2‐4‐(4‐cyanophenyl)‐thiazol‐2‐yl]‐(2,4‐difluorophenyl)‐1‐[1,2,4]triazol‐4‐yl‐methylpropoxymethyl] mono ester dilysine salt, a prodrug of ravuconazole

Synthesis of a labeled inhibitor of HIV‐1 attachment: 1‐(4‐benzoylpiperazin‐1‐yl)‐2‐(4,7‐dimethoxy‐1H‐pyrrolo[2,3‐c]pyridinyl‐3‐yl‐[U‐ 14 C]ethane‐1,2‐dione, BMS‐488043‐ 14 C

Shoulder Surgery: Tricks of the Trade

Synthesis of [13C4]Baraclude® (entecavir)

Synthesis and stability of a carbon-14-labeled 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor

Synthesis of lead LFA-1 antagonist [14C]spyrocyclic hydantoin

The 14 C, 13 C, and 15 N syntheses of a potent VEGFR‐2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate

Synthesis of [13C4,15N2lpyrrolo[2,1-f][1,2,4]triazinone

Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats

Synthesis of 14 C‐labeled and 13 C‐, 15 N‐labeled dasatinib and its piperazine N ‐dealkyl metabolite

Suchergebnisse filtern